FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2803113108> ?p ?o ?g. }

• W2803113108 endingPage "53" @default.
• W2803113108 startingPage "45" @default.
• W2803113108 abstract "Although conventional combination therapy is effective for most patients with rheumatoid arthritis (RA), many still do not respond to current therapies. Therefore, novel combination regimens that better target cellular processes involved in RA pathogenesis are required. Preliminary studies have demonstrated the beneficial effects of a combination of cyclophosphamide (CTX) and methotrexate (MTX) in models of RA. Using western blotting, real-time polymerase chain reaction, enzyme-linked immunosorbent assays, and immunofluorescent staining, we demonstrated that the combination of 4-hydroperoxy CTX (4-H-CTX) and MTX inhibited the expression of receptor activator of nuclear factor-κB ligand (RANKL) in fibroblast-like synoviocytes (FLS) treated with the interleukin (IL)-6/soluble IL-6 receptor (sIL-6R) complex. To elucidate the mechanisms underlying this effect, we treated RA-FLS with the JAK2/STAT3 inhibitor AG490 or p38MAPK inhibitor SB203580. The results showed that IL-6/sIL-6R-induced RANKL upregulation required phosphorylation-mediated activation of STAT3 and p38 signaling, and that 4-H-CTX and/or MTX inhibited RANKL expression in IL-6/sIL-6R-stimulated FLS by suppressing JAK2/STAT3 and p38MAPK signaling. This study demonstrated for the first time the inhibitory effects of 4-H-CTX and MTX on RANKL expression in IL-6/sIL-6R-stimulated FLS via suppression of STAT3 and p38MAPK phosphorylation. These results identify promising therapeutic agents that might have clinical applications in patients with RA who are at high risk of bone erosion or do not respond well to conventional therapy." @default.
• W2803113108 created "2018-06-01" @default.
• W2803113108 creator A5001627310 @default.
• W2803113108 creator A5016299845 @default.
• W2803113108 creator A5019691360 @default.
• W2803113108 creator A5033155675 @default.
• W2803113108 creator A5038721944 @default.
• W2803113108 creator A5048787526 @default.
• W2803113108 creator A5083323004 @default.
• W2803113108 date "2018-08-01" @default.
• W2803113108 modified "2023-09-26" @default.
• W2803113108 title "Combination of 4-hydroperoxy cyclophosphamide and methotrexate inhibits IL-6/sIL-6R-induced RANKL expression in fibroblast-like synoviocytes via suppression of the JAK2/STAT3 and p38MAPK signaling pathway" @default.
• W2803113108 cites W1429505219 @default.
• W2803113108 cites W1817885483 @default.
• W2803113108 cites W1887078028 @default.
• W2803113108 cites W2000468514 @default.
• W2803113108 cites W2003208357 @default.
• W2803113108 cites W2006687938 @default.
• W2803113108 cites W2018977233 @default.
• W2803113108 cites W2021821328 @default.
• W2803113108 cites W2035636765 @default.
• W2803113108 cites W2065276387 @default.
• W2803113108 cites W2066960433 @default.
• W2803113108 cites W2070044720 @default.
• W2803113108 cites W2076357723 @default.
• W2803113108 cites W2105059159 @default.
• W2803113108 cites W2109134094 @default.
• W2803113108 cites W2127938598 @default.
• W2803113108 cites W2128952811 @default.
• W2803113108 cites W2136474272 @default.
• W2803113108 cites W2138784254 @default.
• W2803113108 cites W2171784256 @default.
• W2803113108 cites W2184900550 @default.
• W2803113108 cites W2593097029 @default.
• W2803113108 cites W2736019624 @default.
• W2803113108 cites W2755336301 @default.
• W2803113108 cites W3146337847 @default.
• W2803113108 cites W4211111012 @default.
• W2803113108 cites W941899121 @default.
• W2803113108 doi "https://doi.org/10.1016/j.intimp.2018.05.014" @default.
• W2803113108 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29803913" @default.
• W2803113108 hasPublicationYear "2018" @default.
• W2803113108 type Work @default.
• W2803113108 sameAs 2803113108 @default.
• W2803113108 citedByCount "3" @default.
• W2803113108 countsByYear W28031131082020 @default.
• W2803113108 countsByYear W28031131082021 @default.
• W2803113108 countsByYear W28031131082022 @default.
• W2803113108 crossrefType "journal-article" @default.
• W2803113108 hasAuthorship W2803113108A5001627310 @default.
• W2803113108 hasAuthorship W2803113108A5016299845 @default.
• W2803113108 hasAuthorship W2803113108A5019691360 @default.
• W2803113108 hasAuthorship W2803113108A5033155675 @default.
• W2803113108 hasAuthorship W2803113108A5038721944 @default.
• W2803113108 hasAuthorship W2803113108A5048787526 @default.
• W2803113108 hasAuthorship W2803113108A5083323004 @default.
• W2803113108 hasConcept C104317684 @default.
• W2803113108 hasConcept C11960822 @default.
• W2803113108 hasConcept C127561419 @default.
• W2803113108 hasConcept C170493617 @default.
• W2803113108 hasConcept C185592680 @default.
• W2803113108 hasConcept C203014093 @default.
• W2803113108 hasConcept C2777077863 @default.
• W2803113108 hasConcept C2778923194 @default.
• W2803113108 hasConcept C2779428903 @default.
• W2803113108 hasConcept C2781059491 @default.
• W2803113108 hasConcept C502942594 @default.
• W2803113108 hasConcept C55493867 @default.
• W2803113108 hasConcept C62478195 @default.
• W2803113108 hasConcept C71924100 @default.
• W2803113108 hasConcept C88045685 @default.
• W2803113108 hasConcept C98274493 @default.
• W2803113108 hasConceptScore W2803113108C104317684 @default.
• W2803113108 hasConceptScore W2803113108C11960822 @default.
• W2803113108 hasConceptScore W2803113108C127561419 @default.
• W2803113108 hasConceptScore W2803113108C170493617 @default.
• W2803113108 hasConceptScore W2803113108C185592680 @default.
• W2803113108 hasConceptScore W2803113108C203014093 @default.
• W2803113108 hasConceptScore W2803113108C2777077863 @default.
• W2803113108 hasConceptScore W2803113108C2778923194 @default.
• W2803113108 hasConceptScore W2803113108C2779428903 @default.
• W2803113108 hasConceptScore W2803113108C2781059491 @default.
• W2803113108 hasConceptScore W2803113108C502942594 @default.
• W2803113108 hasConceptScore W2803113108C55493867 @default.
• W2803113108 hasConceptScore W2803113108C62478195 @default.
• W2803113108 hasConceptScore W2803113108C71924100 @default.
• W2803113108 hasConceptScore W2803113108C88045685 @default.
• W2803113108 hasConceptScore W2803113108C98274493 @default.
• W2803113108 hasFunder F4320321001 @default.
• W2803113108 hasLocation W28031131081 @default.
• W2803113108 hasLocation W28031131082 @default.
• W2803113108 hasOpenAccess W2803113108 @default.
• W2803113108 hasPrimaryLocation W28031131081 @default.
• W2803113108 hasRelatedWork W2046820280 @default.
• W2803113108 hasRelatedWork W2078108429 @default.
• W2803113108 hasRelatedWork W2094538516 @default.
• W2803113108 hasRelatedWork W2152057783 @default.
• W2803113108 hasRelatedWork W2348321858 @default.

• next